After the US FDA approved a kidney disease drug, MSD's stock price remained flat but trading volume surged. Recently, it rose 0.50% to $148.81.

After the US FDA approved a kidney disease drug, MSD's stock price remained flat but trading volume surged. Recently, it rose 0.50% to $148.81.